Replenishing the Arsenal: How U.S. Missile Shortages Are Driving Defense ETFs

The U.S. military has depleted much of its stockpile of long-range missiles during its five-month conflict with Iran, raising concerns about readiness for future conflicts, according to CNBC analysis. The rapid consumption of military defense inventories has exposed structural bottlenecks across the defense sector. This signals that replenishing stockpiles will require substantial procurement from defense contractors. Aerospace and defense ETFs provide exposure to the companies tasked with rebuilding these critical defense reserves.Key Takeaways
Prolonged military conflicts have significantly depleted U.S. missile and interceptor stockpiles. Therefore, there may be a surge in procurement contracts for major defense suppliers like Lockheed Martin and RTX Corporation.
Broad aerospace and defense ETFs such as the State Street SPDR S&P Aerospace & Defense ETF (XAR) and the Invesco Aerospace & Defense ETF (PPA) allow investors to capture this growing multi-billion-dollar industry.
High missile production costs and fast utilization rates are potentially prompting military planners to look toward cheaper, scalable alternatives. That means thematic funds like the REX Drone ETF (DRNZ) can be a direct play on next-generation warfare technologies.
The Scale of U.S. Defense SpendingGovernment agencies like the Department of Defense acquire military missiles from these firms through multi-billion dollar production contracts. The U.S. government is rapidly increasing defense spending, highlighted by a record $1.07 trillion Pentagon funding bill advanced by the House of Representatives in June. However, the bill must receive Senate and presidential approval before it can officially go into effect. The exact timeline for when the Senate vote will occur remains uncertain.
Defense contractors such as Lockheed Martin (LMT) and RTX Corporation (RTX) command a large majority of U.S. military missile development and production. Lockheed Martin supplies the U.S. government an assortment of missiles. These range from the Patriot Advanced Capability-3 (PAC-3) air defense missiles to tactical precision-strike missiles such as the Hellfire (AGM-114). Similarly, RTX Corporation is contracted to produce tactical and air defense missiles, including the Tomahawk and Patriot (GEM-T).Missile Exposure Through Defense ETFsFor investors seeking broad exposure to these defense contractors, aerospace & defense ETFs offer a direct route. The iShares U.S. Aerospace & Defense ETF (ITA B+) provides market-cap weighted exposure to U.S. companies in the aerospace and defense sector. Tracking the Dow Jones U.S. Select Aerospace & Defense Index, a 22.5% cap is placed on any individual holding at each rebalance. ITA maintains concentrated exposure across top holdings with GE Aerospace (GE) and RTX Corporation collectively accounting for 38.52% of total assets. The fund has gained 16.95% year to date with inflows of $30.24 million over the same period.
Similarly, the Invesco Aerospace & Defense ETF (PPA A-) provides exposure to U.S. companies in the industrials, aerospace, and defense sectors, with a 10% cap on individual holdings at each quarterly rebalance. The fund tracks the SPADE Defense Index, with top holdings including RTX Corporation at a 8.17% weight and Boeing (BA) at a 7.07% weight. PPA has climbed 17.45% in 2026 with inflows of $642.89 million.
The State Street SPDR S&P Aerospace & Defense ETF (XAR B) provides equal-weighted exposure to U.S. companies in the aerospace and defense sector. The fund tracks the S&P Aerospace & Defense Select Industry with top holdings including VSE Corporation (VSEC) at 3.37% of total assets and RTX corporation at 3.26%. XAR has gained 18.97% and has received $907.04 million in new assets so far in 2026.
See More: ETF Prime: Defense ETFs Draw Billions Amid Global TensionsInvesting in the Future of DefenseThe current missile supply concerns could potentially accelerate a broader shift towards cheaper and more scalable alternatives. Given the high utilization of drones and unmanned aerial vehicle (UAV) systems in Ukraine, the U.S. military may pair missile production with lower-cost alternatives like autonomous systems. The REX Drone ETF (DRNZ) provides targeted exposure to the global drone and UAV industry, focusing primarily on companies involved in defense and commercial applications.
See More: REX Drone ETF DRNZ Glides Past $100 Million AUM Goalpost
Tracking the VettaFi Drone Index, DRNZ allocates 80% of assets to pure-play companies who derive a majority of revenue from drones or UAV-enabling technology. The remaining 20% targets diversified companies, including defense firms with designated UAV divisions. The fund’s top holdings include AeroVironment (AVAV) at a 14.32% weight and Ondas (ONDS) at a 12.78% portfolio weight. DRNZ has returned 8.23% over the course of the year, while receiving $112.11 million in new assets over the same period.
For more news, information, and analysis, visit the Thematic Investing Content Hub.
VettaFi LLC (“VettaFi”) is the index provider for DRNZ which it receives an index licensing fee. However, DRNZ is not issued, sponsored, endorsed, or sold by VettaFi, and VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of DRNZ.
Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.
ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.
For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.
FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.
News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.
Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.
Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.